From: Immune checkpoint receptors in regulating immune reactivity in rheumatic disease
Molecule | Expression | Ligand/receptor | Function |
---|---|---|---|
CD28 | Resting T cells | CD80 or CD86 on APCs | Lowers TCR threshold |
 |  |  | Delivers a co-stimulatory signal |
 |  |  | Promotes T-cell proliferation, survival, cytokine production, T cell-dependent B cell functions [2] |
CTLA-4/CD152 | Resting/activating T cells | Outcompetes CD28 for CD80/CD86 binding | Increased TCR threshold |
 |  |  | Delivers a co-inhibitory signal [2] |
 |  |  | Upregulates indoleamine 2,3-dioxygenase |
 |  |  | CTLA-4-/- mice develop autoimmunity [2] |
PD-1/CD279 | T cells, B cells, DCs, monocytes, NK T cells, exhausted cells and Tregs | PD-L1 on APCs, B cells, and T cells. PD-L2/CD273 on APCs. PD-L1/CD274 can also bind to CD80 | Delivers an inhibitory signal |
 |  |  | Suppresses Bcl-xl [2] |
ICOS/CD278 | Activated T cells, T follicular helper cells | ICOSL/CD275 on APCs and B cells [2] | Induces proliferation |
 |  |  | Propagates germinal center reactions |
 |  |  | Upregulates IL-10 production [2] |
BTLA/CD272 | B cells, DCs, Th1 cells, macrophages | Herpes virus entry mediator [2] | BTLA delivers an inhibitory signal via ITIM and ITSM [2] |
B7-H3/CD276 | B cells, NK cells, T cells, activated monocytes [2] | Unknown | Co-inhibitory and co-stimulatory functions. Suppress antitumor responses [2] |
B7-H4/B7S1/B7x/Vtcn1 | APCs, cancer cells, and mRNA expression on nonhematopoietic tissue [2] | Unknown | Reduces cell proliferation and T cell interleukin-2 production [2] |
B7-H6 | Tumor cells [3] | NKp30 | Binds NKp30 on NK cells resulting in interferon gamma and cytotoxic function [2] |
VISTA/Dies1/Gi24/PD-1H | Highly expressed on murine myeloid cells. Low expression on T cells [2] | Unknown | Inhibits T-cell proliferation, reduces CD44 and CD69 expression [2] |
 |  |  | Increases cell motility [2] |